Val158Met polymorphism in catechol-O-methyltransferase gene associated with risk factors for breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 9, 2003, Pages 838-847

  Hong, Chi Chen ^a   Thompson, Henry J ^b   Jiang, Cheng ^c   Hammond, Geoffrey L ^e   Tritchler, David ^a   Yaffe, Martin ^d   Boyd, Norman F ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL ESTROGEN; ESTROGEN; FOLLITROPIN; GROWTH FACTOR; GROWTH HORMONE; METHIONINE; PROGESTERONE; SEX HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; VALINE;

ADULT; ALLELE; ARTICLE; BODY MASS; BODY SIZE; BREAST CANCER; CANCER RISK; CATECHOL O METHYLTRANSFERASE 2 GENE; CATECHOL O METHYLTRANSFERASE GENE; CONTROLLED STUDY; ENZYME ACTIVITY; ETHNIC DIFFERENCE; FEMALE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GROWTH HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; SKINFOLD THICKNESS; STATISTICAL ANALYSIS;

BREAST; BREAST NEOPLASMS; CANADA; CATECHOL O-METHYLTRANSFERASE; CROSS-SECTIONAL STUDIES; ESTROGENS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; POLYMORPHISM, GENETIC; POSTMENOPAUSE; PREMENOPAUSE; RISK FACTORS;

EID: 0141563677     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Wolfe, J. N. Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer (Phila.), 37: 2486-2492, 1976.
2. Wolfe, J. N. Breast patterns as an index of risk for developing breast cancer. Am. J. Roentgenol., 126: 1130-1139, 1976.
3. Boyd, N. F., Lockwood, G. A., Byng, J., Tritchler, D. L., and Yaffe, M. Mammographic densities and breast cancer risk. Cancer Epidemiol. Biomark. Prev., 7: 1133-1144, 1998.
4. Maskarinec, G., and Meng, L. A case-control study of mammographic densities in Hawaii. Breast Cancer Res. Treat., 63: 153-161, 2000.
5. Boyd, N., Martin, L., Stone, J., Little, L., Minkin, S., and Yaffe, M. A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol. Biomark. Prev., 11: 1048-1053, 2002.
6. Greendale, G. A., Reboussin, B. A., Sie, A., Singh, R., Olson, L. K., Gatewood, O., Bassett, L. W., Wasilauskas, C., Bush, T., and Barrett-Connor, E. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Ann. Intern. Med., 130: 262-269, 1999.
7. Boyd, N. F., Dite, G. S., Stone, J., Gunasekara, A., English, D. R., McCredie, M. R. E., Giles, G. G., Tritchler, D., Chiarelli, A., Yaffe, M. J., and Hopper, J. L. Heritability of mammographic density, a risk factor for breast cancer. N. Engl. J. Med., 347: 886-894, 2002.
8. Yager, J. D., and Liehr, J. G. Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol. Toxicol., 36: 203-232, 1996.
9. Zhu, B. T., and Conney, A. H. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res., 58: 2269-2277, 1998.
10. Pribluda, V. S., Gubish, E. R., Jr., Lavallee, T. M., Treston, A., Swartz, G. M., and Green, S. J. 2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate. Cancer Metastasis Rev., 19: 173-179, 2000.
11. Tenhunen, J., Salminen, M., Lundstrom, K., Kiviluoto, T., Savolainen, R., and Ulmanen, I. Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. Eur. J. Biochem., 223: 1049-1059, 1994.
12. Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y. M., Szumlanski, C. L., and Weinshilboum, R. M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenesis, 6: 243-250, 1996.
13. Boyd, N. F., Stone, J., Martin, L. J., Jong, R., Fishell, E., Yaffe, M., Hammond, G., and Minkin, S. The association of breast mitogens with mammographic densities. Br. J. Cancer, 87: 876-882, 2002.
14. Block, G., Thompson, F. E., Hartman, A. M., Larkin, F. A., and Guire, K. E. Comparison of two dietary questionnaires validated against multiple dietary records collected during a 1-year period. J. Am. Diet. Assoc., 92: 686-693, 1992.
15. Byng, J. W., Boyd, N. F., Fishell, E., Jong, R. A., and Yaffe, M. J. The quantitative analysis of mammographic densities. Phys. Med. Biol., 39: 1629-1638, 1994.
16. Wang, L., Hirayasu, K., Ishizawa, M., and Kobayashi, Y. Purification of genomic DNA from human whole blood by isopropanol-fractionation with concentrated Nal and SDS. Nucleic Acids Res., 22: 1774-1775, 1994.
17. SAS Institute Inc SAS/STAT User's Guide, Version 6. Cary, NC: SAS Institute Inc., 1989.
18. Lavigne, J. A., Helzlsouer, K. J., Huang, H. Y., Strickland, P. T., Bell, D. A., Selmin, O., Watson, M. A., Hoffman, S., Comstock, G. W., and Yager, J. D. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res., 57: 5493-5497, 1997.
19. Byrne, C., Colditz, G. A., Willet, W. C., Speizer, F. E., Pollak, M., and Hankinson, S. E. Plasma insulin-like growth factor (IGF) 1, IGF-binding protein 3, and mammographic density. Cancer Res., 60: 3744-3748, 2000.
20. Hankinson, S. E., Willet, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B., Rosner, B., Speizer, F. E., and Pollak, M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet, 351: 1393-1396, 1998.
21. Meyer, F., Brown, J. B., Morrison, A. S., and MacMahon, B. Endogenous sex hormones, prolactin, and breast cancer in premenopausal women. J. Natl. Cancer Inst. (Bethesda), 77: 613-616, 1986.
22. Ross, R. K., Paganini-Hill, A., Wan, P. C., and Pike, M. C. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J. Natl. Cancer Inst. (Bethesda), 92: 328-332, 2000.
23. Sala, E., Warren, R., McCann, J., Duffy, S., Luben, R., and Day, N. High-risk mammographic parenchymal patterns and anthropometric measures: a case-control study. Br. J. Cancer. 81: 1257-1261, 1999.
24. Vachon, C. M., Kuni, C. C., Anderson, K., Anderson, V. E., and Sellers, T. A. Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control, 11: 653-662, 2000.
25. van den Brandt, P. A., Spiegelman, D., Yaun, S. S., Adami, H. O., Beeson, L., Folsom, A. R., Fraser, G., Goldbohm. R. A., Graham, S., Kushi, L., Marshall, J. R., Miller, A. B., Rohan, T., Smith-Warner, S. A., Speizer, F. E., Willett, W. C., Wolk, A., and Hunter, D. J. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am. J. Epidemiol., 152: 514-527, 2000.
26. Cold, S., Hansen, S., Overvad, K., and Rose, C. A woman's build and the risk of breast cancer. Eur. J. Cancer, 34: 1163-1174, 1998.
27. Hall, I. J., Newman, B., Millikan, R. C., and Moorman, P. G. Body size and breast cancer risk in black women and white women: the Carolina Breast Cancer Study. Am. J. Epidemiol., 151: 754-764, 2000.
28. Palmatier, M. A., Kang, A. M., and Kidd, K. K. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol. Psychiatry, 46: 557-567, 1999.
29. Ruiz-Larrea, M. B., Leal, A. M., Liza, M., Lacort, M., and de Groot, H. Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids. 59: 383-388, 1994.
30. Miura, T., Muraoka, S., and Ogiso, T. Inhibition of lipid peroxidation by estradiol and 2-hydroxyestradiol. Steroids, 61: 379-383, 1996.
31. Lippert, T. H., Seeger, H., and Mueck, A. O. Estradiol metabolism during oral and transdermal estradiol replacement therapy in postmenopausal women. Horm. Metab. Res., 30: 598-600, 1998.
32. Markides, C. S., Roy, D., and Liehr, J. G. Concentration dependence of prooxidant and antioxidant properties of catecholestrogens. Arch. Biochem. Biophys., 360: 105-112, 1998.
33. Boyd, N. F., Connelly, P., Byng, J., Yaffe, M., Draper, H., Little, L., Jones, D., Martin, L. J., Lockwood, G., and Tritchler, D. Plasma lipids, lipoproteins, and mammographic densities. Cancer Epidemiol. Biomark. Prev., 4: 727-733, 1995.
34. Leebaw, W. F., Lee, L. A., and Woolf, P. D. Dopamine affects basal and augmented pituitary hormone secretion. J. Clin. Endocrinol. Metab, 47: 480-487, 1978.
35. Wang, G. J., Volkow, N. D., Logan, J., Pappas, N. R., Wong, C. T., Zhu, W., Netusil, N., and Fowler, J. S. Brain dopamine and obesity. Lancet, 357: 354-357, 2001.
36. Fetissov, S. O., Meguid, M. M., Chen, C., and Miyata, G. Synchronized release of dopamine and serotonin in the medial and lateral hypothalamus of rats. Neuroscience, 101: 657-663, 2000.
37. Bray, G. A. Reciprocal relation of food intake and sympathetic activity: experimental observations and clinical implications. Int. J. Obes. Relat. Metab. Disord., 24 (Suppl. 2): S8-S17, 2000.
38. Ferreira, M. F., Sobrinho, L. G., Santos, M. A., Sousa, M. F., and Uvnas-Moberg, K. Rapid weight gain, at least in some women, is an expression of a neuroendocrine state characterized by reduced hypothalamic dopaminergic tone. Psychoneuroendocrinology, 23: 1005-1013, 1998.
39. Ho, K. Y., Evans, W. S., Blizzard, R. M., Veldhuis, J. D., Merriam, G. R., Samojlik, E., Furlanetto, R., Rogol, A. D., Kaiser, D. L., and Thomer, M. O. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J. Clin. Endocrinol. Metab., 64: 51-58, 1987.
40. Hsueh, A. J., Erickson, G. F., and Yen, S. S. The sensitizing effect of estrogens and catechol estrogen on cultured pituitary cells to luteinizing hormone-releasing hormone: its antagonism by progestins. Endocrinology, 104: 807-813, 1979.
41. Kanzaki, M., and Morris, P. L. Growth hormone regulates steroidogenic acute regulatory protein expression and steroidogenesis in Leydig cell progenitors. Endocrinology, 140: 1681-1686, 1999.
42. LaVoie, H. A., Garmey, J. C., and Veldhuis, J. D. Mechanisms of insulin-like growth factor I augmentation of follicle-stimulating hormone-induced porcine steroidogenic acute regulatory protein gene promoter activity in granulosa cells. Endocrinology, 140: 146-153, 1999.
43. Cummings, D. E., and Merriam, G. R. Age-related changes in growth hormone secretion: should the somatopause be treated? Semin. Reprod. Endocrinol., 17: 311-325, 1999.
44. Haiman, C. A., Bernstein, L., Berg, D., Ingles, S. A., Salane, M., and Ursin, G. Genetic determinants of mammographic density. Breast Cancer Res., 4: R5, 2002.
45. Haiman, C. A., Hankinson, S. E., De, V., I. Guillemette, C., Ishibe, N., Hunter, D. J., and Byrne, C. Polymorphisms in steroid hormone pathway genes and mammographic density. Breast Cancer Res. Treat., 77: 27-36, 2003.
46. Thompson, P. A., Shields, P. G., Freudenheim, J. L., Stone, A., Vena, J. E., Marshall, J. R., Grabara, S., Laughlin, R., Nemoto, T., Kadlubar, F. F., and Ambrosone, C. B. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res., 58: 2107-2110, 1998.
47. Millikan, R. C., Pittman, G. S., Tse, C. K., Duell, E., Newman, B., Savitz, D., Moorman, P. G., Boissy, R. J., and Bell, D. A. Catechol-O-methyltransferase and breast cancer risk. Carcinogenesis (Lond.), 19: 1943-1947, 1998.
48. Huang, C. S., Chem, H. D., Chang, K. J., Cheng, C. W., Hsu, S. M., and Shen, C. Y. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res., 59: 4870-4875, 1999.
49. Yim, D. S., Parkb, S. K., Yoo, K. Y., Yoon, K. S., Chung, H. H., Kang, H. L., Ahn, S. H., Noh, D. Y., Choe, K. J., Jang, I. J., Shin, S. G., Strickland, P. T., Hirvonen, A., and Kang, D. Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer. Pharmacogenetics, 11: 279-286, 2001.
50. Mitrunen, K., Jourenkova, N., Kataja, V., Eskelinen, M., Kosma, V.-M., Benhamou, S., Kang, D., Vainio, H., Uusitupa, M., and Hirvonen, A. Polymorphic catechol-O-methyltransferase gene and breast cancer risk. Cancer Epidemiol. Biomark. Prev., 10: 635-640, 2001.
51. Bergman-Jungestrom, M., and Wingren, S. Catechol-O-methyltransferase (COMT) gene polymorphism and breast cancer risk in young women. Br. J. Cancer, 85: 859-862, 2001.
52. Hamajima, N., Matsuo, K., Tajima, K., Mizutani, M., Iwata, H., Iwase, T., Miura, S., Oya, H., and Obata, Y. Limited association between a catechol-O-methyltransferase (COMT) polymorphism and breast cancer risk in Japan. Int. J. Clin. Oncol., 6: 13-18, 2001.
53. Kocabas, N. A., Sardas, S., Cholerton, S., Daly, A. K., and Karakaya, A. E. Cytochrome P450 CYP1B1 and catechol-O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population. Arch. Toxicol., 76: 643-649, 2002.
54. Hong, Y., Brismar, K., Hall, K., Pedersen, N. L., and de Faire, U. Associations between insulin-like growth factor-I (IGF-I), IGF-binding protein-1, insulin and other metabolic measures after controlling for genetic influences: results from middle-aged and elderly monozygotic twins. J. Endocrinol., 153: 251-257, 1997.
55. Olson, J. E., Atwood, L. D., Grabrick, D. M., Vachon, C. M., and Sellers, T. A. Evidence for a major gene influence on abdominal fat distribution: the Minnesota Breast Cancer Study. Genet. Epidemiol., 20: 458-478, 2001.
56. Shi, R., Berkel, H. J., and Yu, H. Insulin-like growth factor-I and prostate cancer: a meta-analysis. Br. J. Cancer, 85: 991-996, 2001.
57. Giovannucci, E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J. Nutr., 131: 3109S-3120S, 2001.
58. Pouliot, M. C., Despres, J. P., Lemieux, S., Moorjani, S., Bouchard, C., Tremblay, A., Nadeau, A., and Lupien, P. J. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Prev. Cardiol., 73: 460-468, 1994.
59. Sellers, T. A., Sprafka, J. M., Gapstur, S. M., Rich, S. S., Potter, J. D., Ross, J. A., McGovern, P. G., Nelson, C. L., and Folsom, A. R. Does body fat distribution promote familial aggregation of adult onset diabetes mellitus and postmenopausal breast cancer? Epidemiology, 5: 102-108, 1994.